company background image
DIVISLAB

Divi's Laboratories NSEI:DIVISLAB Stock Report

Last Price

₹2.75k

Market Cap

₹730.3b

7D

-17.0%

1Y

-35.7%

Updated

07 Feb, 2023

Data

Company Financials +

Divi's Laboratories Limited

NSEI:DIVISLAB Stock Report

Mkt Cap: ₹730.3b

DIVISLAB Stock Overview

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally.

DIVISLAB fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends5/6

My Notes

New

Notes are coming soon

Divi's Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Divi's Laboratories
Historical stock prices
Current Share Price₹2,750.85
52 Week High₹4,640.80
52 Week Low₹2,740.10
Beta0.21
1 Month Change-19.91%
3 Month Change-16.61%
1 Year Change-35.69%
3 Year Change28.13%
5 Year Change165.40%
Change since IPO31,115.32%

Recent News & Updates

Recent updates

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Nov 08
Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00

Aug 04
Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 21
Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Jul 07
Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Jul 03
Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Apr 03
Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?

Dec 23
Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?

With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting

Sep 02
With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching

Mar 25
Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching

Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Mar 10
Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Feb 23
Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?

Jan 25
Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?

Is Divi's Laboratories Limited's(NSE:DIVISLAB) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jan 07
Is Divi's Laboratories Limited's(NSE:DIVISLAB) Recent Stock Performance Tethered To Its Strong Fundamentals?

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Dec 20
Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

What Type Of Shareholders Own The Most Number of Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Dec 03
What Type Of Shareholders Own The Most Number of Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Jul 30
Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Should You Or Shouldn't You: A Dividend Analysis on Divi's Laboratories Limited (NSE:DIVISLAB)

Jul 17
Should You Or Shouldn't You: A Dividend Analysis on Divi's Laboratories Limited (NSE:DIVISLAB)

Are Divi's Laboratories's (NSE:DIVISLAB) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jul 04
Are Divi's Laboratories's (NSE:DIVISLAB) Statutory Earnings A Good Guide To Its Underlying Profitability?

Shareholder Returns

DIVISLABIN Life SciencesIN Market
7D-17.0%-13.2%-0.8%
1Y-35.7%-28.3%-2.4%

Return vs Industry: DIVISLAB underperformed the Indian Life Sciences industry which returned -28.3% over the past year.

Return vs Market: DIVISLAB underperformed the Indian Market which returned -2.4% over the past year.

Price Volatility

Is DIVISLAB's price volatile compared to industry and market?
DIVISLAB volatility
DIVISLAB Average Weekly Movement4.5%
Life Sciences Industry Average Movement5.1%
Market Average Movement5.7%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.4%

Stable Share Price: DIVISLAB is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: DIVISLAB's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199016,543Kiran Divihttps://www.divislabs.com

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994.

Divi's Laboratories Limited Fundamentals Summary

How do Divi's Laboratories's earnings and revenue compare to its market cap?
DIVISLAB fundamental statistics
Market Cap₹730.26b
Earnings (TTM)₹23.97b
Revenue (TTM)₹83.35b

30.5x

P/E Ratio

8.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DIVISLAB income statement (TTM)
Revenue₹83.35b
Cost of Revenue₹32.58b
Gross Profit₹50.77b
Other Expenses₹26.80b
Earnings₹23.97b

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)90.30
Gross Margin60.91%
Net Profit Margin28.76%
Debt/Equity Ratio0.03%

How did DIVISLAB perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

27%

Payout Ratio